Skip to main content
SpringerLink
Log in

Oncological drug labelling: Japan vs USA

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Jayaputra K, et al. Differences between the United States and Japan in labels of oncological drugs. Pharmacoepidemiology and Drug Safety : 1 Sep 2016. Available from: URL: http://dx.doi.org/10.1002/pds.4111

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Oncological drug labelling: Japan vs USA. Reactions Weekly 1624, 8 (2016). https://doi.org/10.1007/s40278-016-22214-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-016-22214-x

Search

Navigation